FLGC Stock Overview
Engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Flora Growth Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.65 |
| 52 Week High | US$2.75 |
| 52 Week Low | US$0.59 |
| Beta | 1.99 |
| 1 Month Change | -13.85% |
| 3 Month Change | -36.89% |
| 1 Year Change | -71.86% |
| 3 Year Change | -98.27% |
| 5 Year Change | n/a |
| Change since IPO | -99.32% |
Recent News & Updates
Recent updates
Is Flora Growth (NASDAQ:FLGC) Using Too Much Debt?
Mar 27
Flora Growth Corp. (NASDAQ:FLGC) Might Not Be As Mispriced As It Looks After Plunging 25%
Jan 30Flora Growth Corp.'s (NASDAQ:FLGC) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Dec 01Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?
Nov 20The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More
Sep 18Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts
Aug 16Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch
May 22Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story
Apr 04Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%
Feb 17The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More
Dec 22Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding
Apr 17News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts
Dec 08Shareholder Returns
| FLGC | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 4.8% | 0.2% | -1.7% |
| 1Y | -71.9% | -33.9% | 5.6% |
Return vs Industry: FLGC underperformed the US Personal Products industry which returned -33.9% over the past year.
Return vs Market: FLGC underperformed the US Market which returned 5.6% over the past year.
Price Volatility
| FLGC volatility | |
|---|---|
| FLGC Average Weekly Movement | 11.2% |
| Personal Products Industry Average Movement | 7.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: FLGC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: FLGC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 70 | Clifford Starke | www.floragrowth.com |
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Flora Growth Corp. Fundamentals Summary
| FLGC fundamental statistics | |
|---|---|
| Market cap | US$12.62m |
| Earnings (TTM) | -US$15.91m |
| Revenue (TTM) | US$59.51m |
0.2x
P/S Ratio-0.8x
P/E RatioIs FLGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FLGC income statement (TTM) | |
|---|---|
| Revenue | US$59.51m |
| Cost of Revenue | US$47.01m |
| Gross Profit | US$12.50m |
| Other Expenses | US$28.40m |
| Earnings | -US$15.91m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.82 |
| Gross Margin | 21.00% |
| Net Profit Margin | -26.73% |
| Debt/Equity Ratio | 46.1% |
How did FLGC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/30 00:40 |
| End of Day Share Price | 2025/03/28 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Flora Growth Corp. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rommel Dionisio | Aegis Capital Corporation |
| Pablo Zuanic | Cantor Fitzgerald & Co. |
| William Kirk | Roth Capital Partners |